From HAE Dominican Republic

The year 2025 represented a period of strategic and sustained work for the hereditary angioedema patient community in the Dominican Republic. Although many of the actions undertaken during this period did not receive immediate public attention, steady progress was made in fundamental processes aimed at generating real and lasting impacts for patients, their families, and caregivers.

Throughout the year, collaborative work was carried out to build a solid foundation that will allow, in the medium term, the inclusion of medication for the treatment of hereditary angioedema within the national healthcare system. This objective has guided institutional efforts, as well as the actions taken at the technical and medical levels.

During the last quarter of 2025, significant progress was made by reaching out to and establishing relationships with professionals from various healthcare fields, including immunology, intensive care, surgery, dentistry, and anesthesiology. These specialists have expressed interest and willingness to actively collaborate in strengthening comprehensive patient care and achieving the established objectives. This medical support network is expected to continue expanding in the coming period.

The year ends with a positive outlook and clear expectations for 2026, which is projected to be a year of consolidation, growth, and significant progress for the patient community, the allied medical team, the foundation, as well as for the families and caregivers who accompany them throughout this process. The institution remains firmly committed to finding solutions that guarantee a better quality of life and timely access to appropriate treatments for those living with hereditary angioedema in the country.